• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone: A Comprehensive Overview

1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone is a highly specialized organic compound with the CAS number 1245915-41-6. This compound belongs to the class of pyridine derivatives, which have garnered significant attention in the fields of medicinal chemistry and pharmacology due to their diverse biological activities. The molecule features a pyridine ring substituted with a chlorine atom at the 6-position and a trifluoromethyl group at the 5-position, with an ethanone group attached at the 3-position. These structural elements contribute to its unique physicochemical properties and biological functions.

The synthesis of 1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone involves a multi-step process that typically begins with the preparation of the pyridine ring. The introduction of substituents at specific positions is crucial for achieving the desired biological activity. Recent advancements in catalytic methods, such as the use of transition metal catalysts, have enabled more efficient and selective syntheses of such compounds. Researchers have also explored alternative routes, including microwave-assisted synthesis and continuous flow processes, to enhance yield and purity.

One of the most notable applications of 1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone is its role as a lead compound in drug discovery programs targeting various disease states. For instance, studies have demonstrated its potential as a kinase inhibitor, which is a critical class of enzymes involved in cellular signaling pathways. The trifluoromethyl group at the 5-position plays a significant role in modulating the compound's binding affinity to its target protein, while the chlorine atom at the 6-position enhances its lipophilicity, improving bioavailability.

Recent research has also focused on understanding the pharmacokinetic properties of 1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone. In vitro studies have shown that it exhibits favorable absorption profiles and moderate stability in physiological conditions. However, further investigations are required to evaluate its clearance pathways and potential for drug-drug interactions. Preclinical studies in animal models have provided promising results, indicating that this compound could serve as a basis for developing novel therapeutic agents.

The structural versatility of 1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone allows for extensive modification to optimize its pharmacological properties. For example, substituting the ethanone group with other functional groups or altering the positions of substituents on the pyridine ring can significantly impact its activity and selectivity. Collaborative efforts between chemists and biologists have led to the identification of several analogs with enhanced efficacy and reduced toxicity profiles.

In conclusion, 1-(6-Chloro-5-(trifluoromethyl)pyridin-3-yl)ethanone represents a valuable addition to the arsenal of tools available for drug discovery and development. Its unique combination of structural features and biological activities positions it as a promising candidate for addressing unmet medical needs. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, this compound is likely to play an increasingly important role in advancing modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)